批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2016/11/17 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/03/09 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/03/12 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/02/11 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2006/06/09 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/12/14 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/07/31 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/06/01 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/03/10 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/11/19 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/10/20 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/10/20 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/10/15 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/09/06 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/09/22 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/07/30 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/04/01 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/11/05 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/06/12 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:ALPROSTADIL 剂型/给药途径:INJECTABLE;INJECTION 规格:0.01MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020379 |
001 |
NDA |
CAVERJECT |
ALPROSTADIL |
INJECTABLE;INJECTION |
0.01MG/VIAL |
Prescription |
Yes |
No |
AP |
1995/07/06
|
PFIZER |
020649 |
002 |
NDA |
EDEX |
ALPROSTADIL |
INJECTABLE;INJECTION |
0.01MG/VIAL |
Prescription |
Yes |
No |
AP |
1997/06/12
|
AUXILIUM PHARMS LLC |
活性成分:ALPROSTADIL 剂型/给药途径:INJECTABLE;INJECTION 规格:0.02MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020379 |
002 |
NDA |
CAVERJECT |
ALPROSTADIL |
INJECTABLE;INJECTION |
0.02MG/VIAL |
Prescription |
Yes |
Yes |
AP |
1995/07/06
|
PFIZER |
020649 |
003 |
NDA |
EDEX |
ALPROSTADIL |
INJECTABLE;INJECTION |
0.02MG/VIAL |
Prescription |
Yes |
No |
AP |
1997/06/12
|
AUXILIUM PHARMS LLC |
活性成分:ALPROSTADIL 剂型/给药途径:INJECTABLE;INJECTION 规格:0.04MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020379 |
004 |
NDA |
CAVERJECT |
ALPROSTADIL |
INJECTABLE;INJECTION |
0.04MG/VIAL |
Prescription |
Yes |
Yes |
AP |
1997/05/19
|
PFIZER |
020649 |
004 |
NDA |
EDEX |
ALPROSTADIL |
INJECTABLE;INJECTION |
0.04MG/VIAL |
Prescription |
Yes |
Yes |
AP |
1997/06/12
|
AUXILIUM PHARMS LLC |